Stibbe advises Agendia

Stibbe advises Agendia

Stibbe advises Agendia

26.07.2018 NL law

Stibbe advised Agendia on securing a $35 million investment from funds managed by Athyrium Capital Management.

Agendia is a privately held, leading precision oncology company that develops and markets genomic diagnostic products. Proceeds from the financing will accelerate Agendia's commercial expansion in the U.S. and international markets and will enable Agendia to establish new collaborative research programs.


Related experience

Our website uses cookies: third party analytics cookies to best adapt our website to your needs & cookies to enable social media functionalities. For more information on the use of cookies, please check our Privacy and Cookie Policy. Please note that you can change your cookie opt-ins at any time via your browser settings.

Privacy – en cookieverklaring